Rafael Caiado-Vencio1, Paulo Eduardo Albuquerque Zito Raffa2, Bruna Marques Lopes3, Fernanda Lopes Rocha Cobucci4, Raphael Vinícius Gonzaga Vieira5, Paulo Roberto Franceschini6, Paulo Henrique Pires de Aguiar7. 1. Department of Medicine, Pontifical Catholic University of Goiás, Goiânia, Goiás, Brazil. 2. Department of Medicine, Catanduva Medical School (FAMECAUNIFIPA), Catanduva, Brazil. 3. Department of Medicine, Faculty of Medical Sciences, Santa Casa de São Paulo, Brazil. 4. Department of Medicine, Faculdade de Medicina do ABC, Brazil. 5. Department of Neurosurgery, Santa Paula Hospital, São Paulo, Brazil. 6. Department of Neurology and Neurosurgery, University of Caxias do Sul, Rio Grande do Sul, Brazil. 7. Department of Neurology, Pontifical Catholic University of São Paulo, Sao Paulo, Brazil.
Abstract
BACKGROUND: Spinal cord stimulation (SCS) is traditionally performed by implanting surgical leads along the midline of the spinal cord, over the dorsal columns. Here, we present a patient who successfully underwent lateral cervical SCS to treat chronic refractory neuropathic pain. METHODS: A 46-year-old female, with a schwannoma involving the right axillary nerve, presented with a chronic refractory right upper extremity pain syndrome. The tumor was located between the fibers of the teres minor and the posterior deltoid, and measured 2.2 cm in diameter. After 8 months of analgesics, opioids, physiotherapy, and acupuncture, the patient underwent surgery; however, the tumor was unresectable (i.e., due to significant adjacent vascular/neural structures). Three months later, she had a midline C6-C7 laminectomy for placement of a right-sided epidural SCS lead (i.e., containing 16 electrode contacts). RESULTS: Within 4 days following this SCS procedure, the patient's pain completely resolved; at 10 postoperative months, she still remains pain free. CONCLUSION: Lateral SCS at the C6-C7 level provided a safe and effective option for the relief of chronic neuropathic pain attributed to an unresectable schwannoma of the right axillary nerve in a 46-year-old female. Copyright:
BACKGROUND: Spinal cord stimulation (SCS) is traditionally performed by implanting surgical leads along the midline of the spinal cord, over the dorsal columns. Here, we present a patient who successfully underwent lateral cervical SCS to treat chronic refractory neuropathic pain. METHODS: A 46-year-old female, with a schwannoma involving the right axillary nerve, presented with a chronic refractory right upper extremity pain syndrome. The tumor was located between the fibers of the teres minor and the posterior deltoid, and measured 2.2 cm in diameter. After 8 months of analgesics, opioids, physiotherapy, and acupuncture, the patient underwent surgery; however, the tumor was unresectable (i.e., due to significant adjacent vascular/neural structures). Three months later, she had a midline C6-C7 laminectomy for placement of a right-sided epidural SCS lead (i.e., containing 16 electrode contacts). RESULTS: Within 4 days following this SCS procedure, the patient's pain completely resolved; at 10 postoperative months, she still remains pain free. CONCLUSION: Lateral SCS at the C6-C7 level provided a safe and effective option for the relief of chronic neuropathic pain attributed to an unresectable schwannoma of the right axillary nerve in a 46-year-old female. Copyright:
Spinal cord stimulation (SCS) is widely used to treat chronic neuropathic pain.[3,4] Here, we placed a lateral epidural C6-C7 SCS (i.e., containing 16 electrode contacts) in a patient with intractable neuropathic pain attributed to an unresectable right-sided schwannoma of the axillary nerve.
MATERIALS AND METHODS
A 46-year-old female with a schwannoma of the right axillary nerve (i.e., between the fibers of the teres minor and posterior deltoid muscles; it measured 2.2 cm in diameter) presented with chronic refractory pain in the upper right limb. The tumor was located in the right axillary nerve [Figure 1]. After 8 months of unsuccessful pain management therapy (i.e., analgesics, opioids, physiotherapy, and acupuncture), the patient underwent an attempted tumor resection; however, the lesion was unresectable (i.e., due to critical adjacent vascular/neural structures). Three months later, with 9/10 pain on the visual analog scale (VAS) and despite opioids, the patient successfully underwent a C6-C7 laminectomy for the placement of a right lateral SCS. The 16-electrode lead was then routinely connected to the internal pulse generator and placed into a left paramedian lumbar incision [Figures 2 and 3].
Figure 1:
Magnetic resonance imaging showing a schwannoma of the right axillary nerve, between the fibers of the teres minor muscle and the posterior deltoid, with a measure of 2.2 cm in its widest axis (a, b: T1-weighted imaging; c, d: T2-weighted imaging).
Figure 2:
Cervical radiography showing surgical lead position in the lateral epidural space (a: lateral projection; b: anteroposterior projection).
Figure 3:
Magnetic resonance imaging showing lead position in the lateral epidural space. The circle and arrow highlight the appropriate positioning of the surgical lead over the lateral spinal cord (a: sagittal plane; b: axial plane).
Magnetic resonance imaging showing a schwannoma of the right axillary nerve, between the fibers of the teres minor muscle and the posterior deltoid, with a measure of 2.2 cm in its widest axis (a, b: T1-weighted imaging; c, d: T2-weighted imaging).Cervical radiography showing surgical lead position in the lateral epidural space (a: lateral projection; b: anteroposterior projection).Magnetic resonance imaging showing lead position in the lateral epidural space. The circle and arrow highlight the appropriate positioning of the surgical lead over the lateral spinal cord (a: sagittal plane; b: axial plane).
RESULTS
The postoperative MR confirmed the appropriate positioning of the surgical lead at the C6-C7 level in the right lateral epidural space [Figure 3]. Neurostimulation system was turned on 2 days after surgery; programming settings included a frequency of 130 Hz, pulse width of 100 microseconds, and amplitude of 1.8 mA. Four days postoperatively, the patient had complete resolution of pain (0/10 on the VAS) without any surgical complications. Ten months later, the patient still remained pain free.
DISCUSSION
SCS is traditionally performed by the insertion of a surgical lead along the posterior midline of the spinal cord, over the dorsal columns.[4] Recently, the lateral placement of these devices in the cervical spine proved a promising alternative to the routine midline approach. Here, we placed the 16-electrode SCS lead to the right of the midline at the C6-C7 level to treat this 46-year-old female’s chronic pain attributed to an axillary nerve schwannoma.
Efficacy of lateral spinal cord stimulation
Lateral SCS is an effective treatment for neuropathic pain. Although dorsal root ganglion (DRG) stimulation is also an effective treatment for these pain syndrome,[2,4,5,7] we maintain that lateral SCS is safer (i.e., leads in DRG stimulation are implanted through percutaneous punctures with accompanying morbidities). In this case, the right-sided C6-C7 epidural lead was placed under direct visualization without perioperative morbidity. Additional studies have also confirmed the safety/efficacy of placing lateral epidural SCS electrodes to treat chronic pain syndromes [Table 1]. Chandrasekaran et al. reported somatosensory restoration after placing epidural lateral spinal cord stimulators in patients following upper limb amputations [Table 1].[1] Lateral SCS epiradicular stimulation of the C2 DRG has also successfully managed cases of postherpetic neuralgia.[8] Further, Garg et al. used lateral SCS to effectively target complex regional pain syndromes.[6]
Table 1:
Literature on lateral placement of epidural spinal cord stimulators.
Literature on lateral placement of epidural spinal cord stimulators.
CONCLUSION
Lateral cervical epidural SCS proved to be an effective and safe treatment for managing chronic neuropathic pain in a 46-year-old female with an unresectable schwannoma of the right axillary nerve.
Authors: Elena Virginia Colombo; Carlo Mandelli; Pietro Mortini; Giuseppe Messina; Nicola De Marco; Roberto Donati; Claudio Irace; Andrea Landi; Angelo Lavano; Massimo Mearini; Stefano Podetta; Domenico Servello; Edvin Zekaj; Carlo Valtulina; Ivano Dones Journal: Acta Neurochir (Wien) Date: 2015-02-03 Impact factor: 2.216
Authors: Luana Colloca; Taylor Ludman; Didier Bouhassira; Ralf Baron; Anthony H Dickenson; David Yarnitsky; Roy Freeman; Andrea Truini; Nadine Attal; Nanna B Finnerup; Christopher Eccleston; Eija Kalso; David L Bennett; Robert H Dworkin; Srinivasa N Raja Journal: Nat Rev Dis Primers Date: 2017-02-16 Impact factor: 52.329
Authors: Liong Liem; Marc Russo; Frank J P M Huygen; Jean-Pierre Van Buyten; Iris Smet; Paul Verrills; Michael Cousins; Charles Brooker; Robert Levy; Timothy Deer; Jeffrey Kramer Journal: Neuromodulation Date: 2014-08-21
Authors: Timothy R Deer; Robert M Levy; Jeffery Kramer; Lawrence Poree; Kasra Amirdelfan; Eric Grigsby; Peter Staats; Allen W Burton; Abram H Burgher; Jon Obray; James Scowcroft; Stan Golovac; Leonardo Kapural; Richard Paicius; Christopher Kim; Jason Pope; Thomas Yearwood; Sam Samuel; W Porter McRoberts; Hazmer Cassim; Mark Netherton; Nathan Miller; Michael Schaufele; Edward Tavel; Timothy Davis; Kristina Davis; Linda Johnson; Nagy Mekhail Journal: Pain Date: 2017-04 Impact factor: 7.926
Authors: Santosh Chandrasekaran; Ameya C Nanivadekar; Gina McKernan; Eric R Helm; Michael L Boninger; Jennifer L Collinger; Robert A Gaunt; Lee E Fisher Journal: Elife Date: 2020-07-21 Impact factor: 8.140